Antidepressive Agents
Medicine & Life Sciences
100%
Depression
Medicine & Life Sciences
89%
Major Depressive Disorder
Medicine & Life Sciences
87%
Cognitive Behavioral Therapy
Medicine & Life Sciences
83%
Bipolar Disorder
Medicine & Life Sciences
74%
Psychiatry
Medicine & Life Sciences
63%
Japan
Medicine & Life Sciences
57%
Outpatients
Medicine & Life Sciences
47%
Katayama, N. ,
Nakagawa, A. ,
Umeda, S. ,
Terasawa, Y. ,
Abe, T. ,
Kurata, C. ,
Sasaki, Y. ,
Mitsuda, D. ,
Kikuchi, T. ,
Tabuchi, H. &
Mimura, M. ,
2022 2月 1 ,
In: Journal of Affective Disorders. 298 ,
p. 644-655 12 p. 研究成果: Article › 査読
Major Depressive Disorder
99%
Cognitive Behavioral Therapy
97%
Randomized Controlled Trials
64%
Thinking
31%
activation
26%
Shinozaki, M. ,
Yasui-Furukori, N. ,
Adachi, N. ,
Ueda, H. ,
Hongo, S. ,
Azekawa, T. ,
Kubota, Y. ,
Katsumoto, E. ,
Edagawa, K. ,
Goto, E. ,
Miki, K. ,
Kato, M. ,
Nakagawa, A. ,
Kikuchi, T. ,
Tsuboi, T. ,
Watanabe, K. ,
Shimoda, K. &
Yoshimura, R. ,
2022 1月 ,
In: Asian Journal of Psychiatry. 67 , 102935.
研究成果: Article › 査読
Antidepressive Agents
100%
medication
95%
Prescriptions
93%
mood
85%
Outpatients
83%
Ayani, N. ,
Morimoto, T. ,
Sakuma, M. ,
Kikuchi, T. ,
Watanabe, K. &
Narumoto, J. ,
2021 ,
In: Journal of clinical psychopharmacology. 41 ,
4 ,
p. 397-402 6 p. 研究成果: Article › 査読
Polypharmacy
100%
Drug-Related Side Effects and Adverse Reactions
75%
Antipsychotic Agents
74%
Japan
67%
Inpatients
65%
Takamiya, A. ,
Kishimoto, T. ,
Hirano, J. ,
Kikuchi, T. ,
Yamagata, B. &
Mimura, M. ,
2021 8月 30 ,
In: Progress in Neuro-Psychopharmacology and Biological Psychiatry. 110 , 110286.
研究成果: Article › 査読
Electroconvulsive Therapy
100%
Gray Matter
81%
Depression
19%
Brain
19%
Amygdala
10%
Sado, M. ,
Koreki, A. ,
Ninomiya, A. ,
Kurata, C. ,
Mitsuda, D. ,
Sato, Y. ,
Kikuchi, T. ,
Fujisawa, D. ,
Ono, Y. ,
Mimura, M. &
Nakagawa, A. ,
2021 11月 ,
In: Psychiatry and Clinical Neurosciences. 75 ,
11 ,
p. 341-350 10 p. 研究成果: Article › 査読
Treatment-Resistant Depressive Disorder
100%
Cognitive Behavioral Therapy
76%
Cost-Benefit Analysis
64%
Mental Health
58%
Depression
48%